Shimadzu Journal vol.8 Issue1
Ostatní | 2020 | ShimadzuInstrumentace
GC/MSD, GC/MS/MS, GC/QQQ, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ, SFC, PrepLC
ZaměřeníFarmaceutická analýza
VýrobceShimadzu
Klíčová slovasfc, pharmaceutical, ndma, shimadzu, metformin, hydroxychloroquine, preparative, insight, team, customer, project, etc, members, providence, instrument, antibody, development, new, participating, sulfate, features, cancer, pump, impurity, prep, from, report, nexera, drug, scale, ranitidine, biba, mirlinda, nmu, monoclonal, fraction, test, technologies, purifications, impurities, states, instruments, user, enabling, hydrochloride, industry, tablets, medicinal, peak, genotoxic
Podobná PDF
Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances -
2020|Shimadzu|Příručky
Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…
Klíčová slova
ndma, ndmandea, ndeacarcinogenic, carcinogenicsubstances, substancesmutagenic, mutagenicmms, mmsimpurity, impurityems, emsmode, modeims, imsdrug, drugmutagenicity, mutagenicityolmesartan, olmesartanndba, ndbapharmaceuticals
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|PříručkyPrezentace
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Klíčová slova
back, backndma, ndmaneipa, neipafda, fdandipa, ndipandea, ndeandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apivalsartan, valsartanbest, bestquant, quantcandesartan
Nitrosamine impurities analysis solution guide
2021|Thermo Fisher Scientific|Příručky
Nitrosamine impurities analysis solution guide • Find the right analytical solution for each stage of nitrosamine impurity analysis • Confidently detect and quantify genotoxic impurities in active pharmaceutical ingredients and finished drug products Table of contents Monitoring genotoxic impurities in…
Klíčová slova
nitrosamine, nitrosaminepage, pagehram, hramcontents, contentsnext, nextimpurity, impurityback, backresources, resourceslearn, learnmetformin, metforminsoftware, softwarevalsartan, valsartansolution, solutionmass, massthermo
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Ostatní
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Klíčová slova
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapmass, massaquisition, aquisitionexactive, exactivesource, sourceloop, loopkpa